The Current Ratio as of December 2024 (TTM) for Bio-Techne Corporation (TECH) is 4.56

According to Bio-Techne Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 4.56. This represents a change of 8.13% compared to the average of 4.22 of the last 4 quarters.

Bio-Techne Corporation (TECH) Historical Current Ratio (quarterly & annually)

How has TECH Current Ratio performed in the past?

The mean historical Current Ratio of Bio-Techne Corporation over the last ten years is 4.30. The current 4.56 Current Ratio has changed 10.52% with respect to the historical average. Over the past ten years (40 quarters), TECH's Current Ratio was at its highest in in the March 2015 quarter at 7.65. The Current Ratio was at its lowest in in the March 2017 quarter at 2.15.

Bio-Techne Corporation (TECH) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Bio-Techne Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Bio-Techne Corporation (TECH) Average Current Ratio

How has TECH Current Ratio performed in the past?

The current Current Ratio of Bio-Techne Corporation (TECH) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Bio-Techne Corporation (TECH) Current Ratio vs. Peers

How is TECH’s Current Ratio compared to its peers?

Bio-Techne Corporation’s Current Ratio is greater than BioMarin Pharmaceutical Inc. (4.27), less than Vaxcyte, Inc. (17.88), less than Liquidia Corporation (6.33), less than Legend Biotech Corporation (4.98), greater than Seagen Inc. (2.67), greater than Alnylam Pharmaceuticals, Inc. (2.75), greater than Exelixis, Inc. (3.93), less than Halozyme Therapeutics, Inc. (10.36), less than Replimune Group, Inc. (10.11), less than Nuvalent, Inc. (23.07), less than Ventyx Biosciences, Inc. (23.52), greater than Ascendis Pharma A/S (1.16), less than United Therapeutics Corporation (4.58), greater than Apellis Pharmaceuticals, Inc. (4.36), greater than BeiGene, Ltd. (1.93), less than Akero Therapeutics, Inc. (17.25), greater than Blueprint Medicines Corporation (3.32), greater than Travere Therapeutics, Inc. (1.71),

Build a custom stock screener for Bio-Techne Corporation (TECH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bio-Techne Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bio-Techne Corporation (TECH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bio-Techne Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.